Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.905 USD | -0.64% | +0.90% | +11.25% |
Apr. 04 | North American Morning Briefing : Focus Turns to -2- | DJ |
Apr. 03 | Oppenheimer Upgrades Aldeyra Therapeutics to Outperform From Perform, $10 Price Target | MT |
Financials (USD)
Sales 2024 * | 28.43M | Sales 2025 * | 22.31M | Capitalization | 232M |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | -23M | EV / Sales 2024 * | 8.16 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 10.4 x |
P/E ratio 2024 * |
-78.6
x | P/E ratio 2025 * |
-10.4
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 82.24% |
Latest transcript on Aldeyra Therapeutics, Inc.
1 day | -0.64% | ||
1 week | +0.90% | ||
Current month | +19.42% | ||
1 month | +35.59% | ||
3 months | +27.20% | ||
6 months | +162.08% | ||
Current year | +11.25% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Brady
CEO | Chief Executive Officer | 52 | 05-08-31 |
Bruce Greenberg
DFI | Director of Finance/CFO | 56 | 19-11-30 |
Caitlin Pazzano
PRN | Corporate Officer/Principal | - | 21-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Phillips
BRD | Director/Board Member | 58 | 09-04-30 |
Martin Joyce
BRD | Director/Board Member | 70 | 13-09-30 |
Ben Bronstein
BRD | Director/Board Member | 74 | 10-05-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 3.93 | +1.81% | 372,085 |
24-04-19 | 3.86 | -3.02% | 429,655 |
24-04-18 | 3.98 | +0.25% | 432,657 |
24-04-17 | 3.97 | +2.58% | 637,496 |
24-04-16 | 3.87 | -6.97% | 725,191 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.25% | 231M | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- ALDX Stock